0001144204-19-042624.txt : 20190829 0001144204-19-042624.hdr.sgml : 20190829 20190829190021 ACCESSION NUMBER: 0001144204-19-042624 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190827 FILED AS OF DATE: 20190829 DATE AS OF CHANGE: 20190829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weyer Christian CENTRAL INDEX KEY: 0001493811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 191067552 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 10 HUDSON YARDS, 37TH FLOOR CITY: New York STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20031113 4 1 tv528487_4.xml OWNERSHIP DOCUMENT X0306 4 2019-08-27 0 0001270073 INTERCEPT PHARMACEUTICALS, INC. ICPT 0001493811 Weyer Christian C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001 0 1 0 0 EVP, Research & Development Common Stock 2019-08-27 4 F 0 357 60.50 D 18301 D Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person. /s/ Mark Pruzanski, as attorney-in-fact 2019-08-29